Technology

Zai Lab

$181.76
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.47 (-0.26%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Zai Lab and other stocks, options, and ETFs commission-free!

About ZLAB

Zai Lab Limited American Depositary Shares, also called Zai Lab, is a biopharmaceutical company. It engages in the discovering, licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need in the fields of oncology, infectious and autoimmune diseases. The company's products include Zejula and Optune. Zai Lab was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China. The listed name for ZLAB is Zai Lab Limited American Depositary Shares.

CEO
Ying Samantha Du
Employees
692
Headquarters
Shanghai, Shanghai
Founded
2014
Market Cap
16.43B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
470.34K
High Today
$187.40
Low Today
$180.24
Open Price
$182.23
Volume
266.64K
52 Week High
$193.54
52 Week Low
$43.06

Collections

ZLAB Earnings

-$1.37
-$0.91
-$0.46
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 5, Pre-Market

You May Also Like

CAPL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure